Numerous life-threatening rare diseases are due to single gene mutations that manifest within several months of birth. With no effective treatment options, these monogenic diseases require constant and expensive care. Gene therapy is beginning to show clinical promise as a strategy for treating rare diseases, but faces challenges around safe, consistent, and durable gene delivery to targeted tissues. This symposium will explore recent advances in gene therapy for rare diseases, identify issues that remain to be addressed in order for gene therapy to become more widely used, and explore opportunities for application to other disease areas.
Call for Poster Abstracts
Abstract submissions are invited for a poster session. For complete submission instructions, please send an email to RareDiseases@nyas.org with the words "Abstract Information" in the subject line. The deadline for abstract submission is March 10, 2017.
|Member (Student / Postdoc / Fellow)
|Nonmember (Student / Postdoc / Fellow)
The Biochemical Pharmacology Discussion Group is proudly supported by:
ACS New York Section